LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 24

Search options

  1. Article ; Online: Randomized Multicenter Trial for the Validation of an Easy to Administer Algorithm to Define Penicillin Allergy Status in Sexually Transmitted Infection Clinic Outpatients.

    Lillis, Rebecca A / Barbee, Lindley A / McNeil, Candice J / Newman, Lori / Fortenberry, J Dennis / Alvarez-Arango, Santiago / Zenilman, Jonathan M

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2024  

    Abstract: Background: Approximately 15% of patients in sexually transmitted infection (STI) clinics report penicillin allergies, complicating treatment for syphilis and gonorrhea. Nonetheless,  > 90% do not have a penicillin allergy when evaluated. We developed ... ...

    Abstract Background: Approximately 15% of patients in sexually transmitted infection (STI) clinics report penicillin allergies, complicating treatment for syphilis and gonorrhea. Nonetheless,  > 90% do not have a penicillin allergy when evaluated. We developed and validated an algorithm to define which patients reporting penicillin allergy can be safely treated at STI clinics with these drugs.
    Methods: RCT to assess feasibility and safety of penicillin allergy evaluations in STI clinics. Participants with reported penicillin allergy answered an expert-developed questionnaire to stratify risk. Low-risk participants underwent penicillin skin testing (PST) followed by amoxicillin 250 mg challenge or a graded oral challenge (GOC)-amoxicillin 25 mg followed by 250 mg. Reactions were recorded, and participant/provider surveys were conducted.
    Results: Of 284 participants, 72 (25.3%) were deemed high-risk and were excluded. Of 206 low-risk participants, 102 (49.5%) underwent PST without reactions and 3 (3%) had mild reactions during the oral challenge. Of 104 (50.5%) participants in the GOC, 95 (91.3%) completed challenges without reaction, 4 (4.2%) had mild symptoms after 25 mg and 4 (4.2%) after 250 mg doses. Overall, 195 participants (94.7%) successfully completed the study and 11 (5.3%) experienced mild symptoms. Of 14 providers, 12 (85.7%) completed surveys and 11 (93%) agreed on the safety/effectiveness of penicillin allergy assessment in STI clinics.
    Conclusion: An easy-to-administer risk assessment questionnaire can safely identify patients for penicillin allergy evaluation in STI clinics by PST or GOC, with GOC showing operational feasibility. Using this approach, 67% of participants with reported penicillin allergy could safely receive first-line treatments for gonorrhea or syphilis.
    Language English
    Publishing date 2024-02-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciae064
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Reconsidering Presumptive Neisseria gonorrhoeae Treatment For Women With Cervicitis.

    Nsuami, M Jacques / Lillis, Rebecca A / Martin, David H

    Sexually transmitted diseases

    2020  Volume 47, Issue 6, Page(s) 383–386

    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Azithromycin/therapeutic use ; Ceftriaxone/therapeutic use ; Doxycycline/therapeutic use ; Female ; Gonorrhea/drug therapy ; Humans ; Neisseria gonorrhoeae/drug effects ; Neisseria gonorrhoeae/isolation & purification ; Uterine Cervicitis/drug therapy ; Uterine Cervicitis/microbiology
    Chemical Substances Anti-Bacterial Agents ; Ceftriaxone (75J73V1629) ; Azithromycin (83905-01-5) ; Doxycycline (N12000U13O)
    Language English
    Publishing date 2020-03-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 435191-5
    ISSN 1537-4521 ; 0148-5717
    ISSN (online) 1537-4521
    ISSN 0148-5717
    DOI 10.1097/OLQ.0000000000001156
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women.

    Muzny, Christina A / Mena, Leandro A / Lillis, Rebecca A / Schmidt, Norine / Martin, David H / Kissinger, Patricia

    Sexually transmitted diseases

    2021  Volume 49, Issue 3, Page(s) 231–236

    Abstract: Background: In a randomized controlled trial of 2 g (single-dose) metronidazole (MTZ) versus 500 mg twice daily for 7 days (multidose) for Trichomonas vaginalis treatment, multidose was superior. We examined if the effect was similar by select clinical ... ...

    Abstract Background: In a randomized controlled trial of 2 g (single-dose) metronidazole (MTZ) versus 500 mg twice daily for 7 days (multidose) for Trichomonas vaginalis treatment, multidose was superior. We examined if the effect was similar by select clinical factors to determine if treatment recommendations could be targeted.
    Methods: The primary outcome was T. vaginalis repeat infection at test-of-cure (TOC) 4 weeks after completion of therapy. Analyses were stratified by T. vaginalis history, baseline genital symptoms, and concurrent diagnosis of bacterial vaginosis (BV) per Nugent score at baseline.
    Results: Women who returned for TOC (n = 540) were included. At baseline, 52.9% had a self-reported history of T. vaginalis; 79.3%, genital symptoms; 5.8%, a gonorrhea diagnosis; and 47.5%, BV. During follow-up, 97.4% took all MTZ as instructed and 34.5% had interval condomless sex with a baseline partner. At TOC, 14.8% tested positive for T. vaginalis. In stratified analysis, women randomized to single-dose MTZ had a higher rate of TOC T. vaginalis positivity than those randomized to multidose if they were symptomatic at baseline (21.4% vs. 10.8%, P = 0.003) or had a reported history of T. vaginalis (24.1% vs. 12.6%, P = 0.01). Test-of-cure T. vaginalis positivity was higher for women receiving a single dose (18.9%) versus multidose (10.8%), irrespective of baseline BV status (P > 0.06). In multivariable analysis, only a history of T. vaginalis and single-dose MTZ were independently associated with a positive TOC for T. vaginalis.
    Conclusions: Although multidose MTZ is recommended for all women with T. vaginalis, it is especially important for women with a T. vaginalis history and, given high posttreatment infection rates, a TOC should be performed.
    MeSH term(s) Female ; Humans ; Metronidazole ; Trichomonas Vaginitis/complications ; Trichomonas Vaginitis/diagnosis ; Trichomonas Vaginitis/drug therapy ; Trichomonas vaginalis ; Vaginosis, Bacterial/complications ; Vaginosis, Bacterial/diagnosis ; Vaginosis, Bacterial/drug therapy
    Chemical Substances Metronidazole (140QMO216E)
    Language English
    Publishing date 2021-11-20
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 435191-5
    ISSN 1537-4521 ; 0148-5717
    ISSN (online) 1537-4521
    ISSN 0148-5717
    DOI 10.1097/OLQ.0000000000001574
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans.

    Lillis, Rebecca A / Martin, David H / Nsuami, M Jacques

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2018  Volume 69, Issue 3, Page(s) 459–465

    Abstract: Background: Mycoplasma genitalium has been significantly and nonsignificantly associated with cervicitis, urethritis, or vaginal discharge. This study examined the associations of M. genitalium with selected sexually transmitted infections (STIs) and ... ...

    Abstract Background: Mycoplasma genitalium has been significantly and nonsignificantly associated with cervicitis, urethritis, or vaginal discharge. This study examined the associations of M. genitalium with selected sexually transmitted infections (STIs) and demographic, behavioral, and clinical factors among women attending a sexually transmitted disease (STD) clinic in New Orleans.
    Methods: Women aged ≥18 years who presented to the New Orleans STD clinic provided sociodemographic data and sexual behavior; STI, obstetric, and gynecologic history; and urine, vaginal, endocervical, and rectal specimens. Specimens were tested for M. genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma hominis, Ureaplasma species, and yeast. Bacterial vaginosis (BV) was diagnosed by Nugent score, and cervicitis was defined as ≥30 polymorphonuclear leukocytes per high-power microscopic field on a cervical Gram stain or yellow mucopus on an endocervical swab.
    Results: Among 400 women studied, M. genitalium was independently significantly associated with age <25 years (P < .03) and with ≥2 sexual partners in the last 12 months (P < .003). Neisseria gonorrhoeae (adjusted odds ratio [AOR], 1.75; P = .103), C. trachomatis (AOR, 1.43; P = .247), and T. vaginalis (AOR, 1.60; P = .120) independently increased the odds of infection with M. genitalium. Controlling for other STIs and BV, there was a positive trend for M. genitalium to predict cervicitis (AOR, 3.18 [95% confidence interval, .99-10.2]; P = .05).
    Conclusions: Mycoplasma genitalium in our study displayed the clinical features of C. trachomatis and N. gonorrhoeae, the 2 organisms that drive research agendas in diagnosis, treatment, and prevention of bacterial STIs.
    MeSH term(s) Adolescent ; Adult ; Age Factors ; Cervix Uteri/microbiology ; Cross-Sectional Studies ; Female ; Humans ; Middle Aged ; Mycoplasma Infections/epidemiology ; Mycoplasma Infections/microbiology ; Mycoplasma genitalium ; New Orleans/epidemiology ; Prevalence ; Prospective Studies ; Sexual Partners ; Sexually Transmitted Diseases, Bacterial/epidemiology ; Sexually Transmitted Diseases, Bacterial/microbiology ; Vagina/microbiology ; Vaginosis, Bacterial/epidemiology ; Young Adult
    Language English
    Publishing date 2018-10-17
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciy922
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A novel

    Elnaggar, Jacob H / Ardizzone, Caleb M / Cerca, Nuno / Toh, Evelyn / Łaniewski, Paweł / Lillis, Rebecca A / Herbst-Kralovetz, Melissa M / Quayle, Alison J / Muzny, Christina A / Taylor, Christopher M

    Frontiers in cellular and infection microbiology

    2023  Volume 13, Page(s) 1198113

    Abstract: Bacterial vaginosis (BV) is the most common vaginal dysbiosis. In this condition, a polymicrobial biofilm develops on vaginal epithelial cells. Accurately quantifying the bacterial burden of the BV biofilm is necessary to further our understanding of BV ... ...

    Abstract Bacterial vaginosis (BV) is the most common vaginal dysbiosis. In this condition, a polymicrobial biofilm develops on vaginal epithelial cells. Accurately quantifying the bacterial burden of the BV biofilm is necessary to further our understanding of BV pathogenesis. Historically, the standard for calculating total bacterial burden of the BV biofilm has been based on quantifying
    MeSH term(s) Female ; Humans ; Gardnerella/genetics ; Lactobacillus/genetics ; Reproducibility of Results ; Gardnerella vaginalis/genetics ; Prevotella/genetics ; RNA, Ribosomal, 16S/genetics ; Escherichia coli/genetics ; Vagina/microbiology ; Bacteria/genetics ; Vaginosis, Bacterial/microbiology ; Microbiota/genetics
    Chemical Substances RNA, Ribosomal, 16S
    Language English
    Publishing date 2023-06-19
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2023.1198113
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Clinical Evaluation of a New Molecular Test for the Detection of Organisms Causing Vaginitis and Vaginosis.

    Lillis, Rebecca A / Parker, R Lamar / Ackerman, Ronald / Ackerman, Jamie / Young, Stephen / Weissfeld, Alice / Trevino, Ernest / Nachamkin, Irving / Crane, LaShonda / Brown, Jacqueline / Huang, Christina / Liu, Xiaohong / Van Der Pol, Barbara

    Journal of clinical microbiology

    2023  Volume 61, Issue 3, Page(s) e0174822

    Abstract: In this prospective, observational, method comparison clinical study, the Xpert Xpress MVP test (MVP) was evaluated using both clinician-collected (CVS) and self-collected vaginal swabs (SVS) collected in a clinical setting. The study was conducted at 12 ...

    Abstract In this prospective, observational, method comparison clinical study, the Xpert Xpress MVP test (MVP) was evaluated using both clinician-collected (CVS) and self-collected vaginal swabs (SVS) collected in a clinical setting. The study was conducted at 12 sites, including point-of-care (POC) settings, from geographically diverse locations in the United States. Participants were biologically female patients ≥ 14 years old with signs and/or symptoms of vaginitis/vaginosis. MVP test results for BV were compared to the BD MAX Vaginal Panel (BDVP). Results for Candida group and Candida glabrata and Candida krusei targets (species not differentiated) were assessed relative to yeast culture followed by mass spectrometry for species identification. Trichomonas vaginalis (TV) results were compared relative to a composite method that included results from the BDVP and InPouch TV culture. The investigational test demonstrated high positive percent agreement ranging from 93.6 to 99.0%, and negative percent agreement ranging from 92.1% to 99.8% for both CVS and SVS specimens, indicating it may be a valuable tool for the diagnosis of vaginitis/vaginosis in laboratory and POC settings.
    MeSH term(s) Humans ; Female ; Adolescent ; Trichomonas Vaginitis/diagnosis ; Candidiasis, Vulvovaginal/diagnosis ; Vaginosis, Bacterial/diagnosis ; Prospective Studies ; Vagina ; Trichomonas vaginalis/genetics
    Language English
    Publishing date 2023-02-28
    Publishing country United States
    Document type Observational Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 390499-4
    ISSN 1098-660X ; 0095-1137
    ISSN (online) 1098-660X
    ISSN 0095-1137
    DOI 10.1128/jcm.01748-22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.

    Essajee, Nabil M / Oddo-Moise, Hope / Hagensee, Michael E / Lillis, Rebecca A / Maffei, Joanne / Butler, Isolde / Lovett, Aish / Sokol, Theresa / Clement, Meredith E

    AIDS research and human retroviruses

    2023  Volume 39, Issue 11, Page(s) 587–592

    Abstract: The 2022 outbreak of mpox in Louisiana was limited to just >300 cases, perhaps an unexpected outcome given the state's high rates of HIV and other sexually transmitted infections (STIs). We aimed to describe the local outbreak within two health centers ... ...

    Abstract The 2022 outbreak of mpox in Louisiana was limited to just >300 cases, perhaps an unexpected outcome given the state's high rates of HIV and other sexually transmitted infections (STIs). We aimed to describe the local outbreak within two health centers in the New Orleans region, partnering with the Louisiana Department of Health to offer additional statewide data. We reviewed charts of persons testing positive for mpox in New Orleans from July to November 2022 at two local health centers that together accounted for half of local cases. We abstracted data on HIV status, immune function [CD4 count, viral load (VL)], antiretroviral therapy regimen, symptoms and severity of infection, vaccination status, and whether tecovirimat was administered. We present local data relative to statewide data (July 2022-January 2023). Of 103 individuals in our network for whom charts were reviewed, 96 (93%) identified as male, 52 (50%) were Black, and 69 (67%) had HIV, including 12 (17%) with uncontrolled HIV (CD4 < 200 cells/mm
    MeSH term(s) Humans ; Male ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Mpox (monkeypox) ; Sexually Transmitted Diseases/epidemiology ; Louisiana/epidemiology ; CD4 Lymphocyte Count
    Language English
    Publishing date 2023-08-07
    Publishing country United States
    Document type Review ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 639130-8
    ISSN 1931-8405 ; 0889-2229
    ISSN (online) 1931-8405
    ISSN 0889-2229
    DOI 10.1089/AID.2023.0011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Association of

    Ardizzone, Caleb M / Taylor, Christopher M / Toh, Evelyn / Lillis, Rebecca A / Elnaggar, Jacob H / Lammons, John W / Mott, Patricia Dehon / Duffy, Emily L / Shen, Li / Quayle, Alison J

    Frontiers in cellular and infection microbiology

    2023  Volume 13, Page(s) 1289449

    Abstract: Bacterial vaginosis (BV), a dysbiosis of the vaginal microbiota, is a common coinfection ... ...

    Abstract Bacterial vaginosis (BV), a dysbiosis of the vaginal microbiota, is a common coinfection with
    MeSH term(s) Female ; Humans ; Vaginosis, Bacterial/diagnosis ; Metronidazole/pharmacology ; Metronidazole/therapeutic use ; Chlamydia trachomatis/genetics ; RNA, Ribosomal, 16S/genetics ; Vagina/microbiology ; Microbiota
    Chemical Substances Metronidazole (140QMO216E) ; RNA, Ribosomal, 16S
    Language English
    Publishing date 2023-12-12
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2023.1289449
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization.

    Ardizzone, Caleb M / Albritton, Hannah L / Lillis, Rebecca A / Bagnetto, Caitlyn E L / Shen, Li / Cavacini, Lisa A / Kozlowski, Pamela A / Quayle, Alison J

    PloS one

    2021  Volume 16, Issue 10, Page(s) e0258759

    Abstract: The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-derived ... ...

    Abstract The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-derived IgG and IgA from women with a recent positive Ct test to neutralize Ct elementary bodies (EBs) and inhibit inclusion formation in vitro in human endocervical epithelial cells. We also determined if neutralization was influenced by the major outer membrane protein (MOMP) of the infecting strain, as indicated by ompA gene sequencing and genotyping. At equivalent low concentrations of Ct EB (D/UW-3/Cx + E/UW-5/Cx)-specific antibody, genital-derived IgG and IgA and serum IgA, but not serum IgG, significantly inhibited inclusion formation, with genital IgA being most effective, followed by genital IgG, then serum IgA. The well-characterized Ct genotype D strain, D/UW-3/Cx, was neutralized by serum-derived IgG from patients infected with genotype D strains, genital IgG from patients infected with genotype D or E strains, and by genital IgA from patients infected with genotype D, E, or F strains. Additionally, inhibition of D/UW-3/Cx infection by whole serum, rather than purified immunoglobulin, was associated with levels of serum EB-specific IgG rather than the genotype of infecting strain. In contrast, a Ct genotype Ia clinical isolate, Ia/LSU-56/Cx, was neutralized by whole serum in a genotype and genogroup-specific manner, and inhibition also correlated with EB-specific IgG concentrations in serum. Taken together, these data suggest that (i) genital IgA most effectively inhibits Ct infection in vitro, (ii) human antibody-mediated inhibition of Ct infection is significantly influenced by the ompA genotype of the infecting strain, (iii) the genital antibody repertoire develops or matures differently compared to systemic antibody, and (iv) ompA genotype-specificity of inhibition of infection by whole serum can be overcome by high concentrations of Ct-specific IgG.
    MeSH term(s) Adult ; Antibodies, Bacterial/blood ; Antibodies, Bacterial/metabolism ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/metabolism ; Bacterial Outer Membrane Proteins/genetics ; Bacterial Outer Membrane Proteins/immunology ; Cell Line ; Cervix Uteri/cytology ; Cervix Uteri/immunology ; Cervix Uteri/virology ; Chlamydia Infections/immunology ; Chlamydia trachomatis/genetics ; Chlamydia trachomatis/immunology ; Epithelial Cells/cytology ; Epithelial Cells/immunology ; Epithelial Cells/virology ; Female ; Genotype ; Humans ; Immunoglobulin A/blood ; Immunoglobulin A/metabolism ; Immunoglobulin G/blood ; Immunoglobulin G/metabolism ; Phylogeny ; Sequence Analysis, DNA ; Young Adult
    Chemical Substances Antibodies, Bacterial ; Antibodies, Neutralizing ; Bacterial Outer Membrane Proteins ; Immunoglobulin A ; Immunoglobulin G ; OMPA outer membrane proteins (149024-69-1)
    Language English
    Publishing date 2021-10-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0258759
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Syphilis and HIV: a review for clinicians as this centuries-old disease makes a comeback.

    Lillis, Rebecca A

    HIV clinician

    2005  Volume 17, Issue 3, Page(s) 1–4

    MeSH term(s) Europe/epidemiology ; HIV Infections/complications ; Humans ; Penicillin G Benzathine/therapeutic use ; Syphilis/complications ; Syphilis/diagnosis ; Syphilis/drug therapy ; Syphilis/epidemiology ; United States/epidemiology
    Chemical Substances Penicillin G Benzathine (RIT82F58GK)
    Language English
    Publishing date 2005
    Publishing country United States
    Document type Newspaper Article
    ISSN 1551-885X
    ISSN 1551-885X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top